FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Assured Investment Management LLC 2. Issuer Name and Ticker or Trading Symbol AdaptHealth Corp. [ AHCO ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)__X__ Director                    _____ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)         (First)         (Middle)
280 PARK AVENUE, 12TH FLOOR
3. Date of Earliest Transaction (MM/DD/YYYY)
10/16/2020
(Street)
NEW YORK, NY 10017
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Put Option (Right to Sell) (1)(2)(3)(4)(5)(6) $14.50 (4) 10/16/2020    D (3)       1898967    (3)(5) 10/31/2020  Class A and B Common Stock (6) 1898967  $0.00  0  I  Footnotes (1)(2)
Call Option (Obligation to Sell) (1)(2)(3)(4)(5)(6) $15.76  10/16/2020    A (3)    1898967       (3)(5) 10/31/2020  Class A and B Common Stock (6) 1898967  $0.00  0  I  Footnotes (1)(2)
Put Option (Right to Sell) (1)(2)(3)(4)(5)(6) $14.50 (4) 10/16/2020    A (3)    1898967       (3)(5) 10/31/2020  Class A and B Common Stock (6) 1898967  $0.00  1898967  I  Footnotes (1)(2)
Call Option (Obligation to Sell) (1)(2)(3)(4)(5)(6) $15.76  10/16/2020    D (3)       1898967    (3)(5) 10/31/2020  Class A and B Common Stock (6) 1898967  $0.00  1898967  I  Footnotes (1)(2)

Explanation of Responses:
(1)  The filing of this Form 4 shall not be construed as an admission that Assured Investment Management LLC (f/k/a BlueMountain Capital Management, LLC) ("AssuredIM") is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any put options ("Put Options") relating to shares of Class A Common Stock, par value $0.0001 per share "Class A Common Stock") and Class B Common Stock, par value $0.0001 per share ("Class B Common Stock"), of AdaptHealth Corp. (the "Issuer"). Pursuant to Rule 16a-1(a)(4) of the Exchange Act, AssuredIM disclaims such beneficial ownership, except to the extent of its pecuniary interest.
(2)  AssuredIM is the investment manager of each of: (i) BMSB L.P. ("BMSB"); (ii) BlueMountain Fursan Fund L.P. ("FRSN"); (iii) BlueMountain Foinaven Master Fund L.P. ("BMFV"); and (iv) BlueMountain Summit Opportunities Fund II (US) L.P. (together with BMSB, FRSN and BMFV, the "Funds"), which collectively are the direct beneficial owners of 1,898,967 Put Options. AssuredIM, although it directs the exercise of the Put Options held by the Funds, only receives an asset-based fee relating to the Put Options held by the Funds.
(3)  In a Form 4 filed on May 27, 2020, the Funds reported that they entered into Put/Call Option and Consent Agreement (the "Option Agreement") dated as of May 25, 2020 with the Issuer pursuant to which the Funds acquired the Put Options from the Issuer and issued to the Issuer call options with respect to the Class A Common Stock and Class B Common Stock of the Issuer (the "Call Options"), each of which options expired on October 31, 2020. On October 16, 2020 the Issuer and the Funds entered into an Amendment to the Option Agreement (the "Amendment") that extended the expiration date of both the Put Options and the Call Options to December 31, 2020. The Amendment is reported in this Form 4 as (i) a cancellation of the original Put Options and Call Options and (ii) an issuance of replacement Put Options by the Issuer to the Funds and replacement Call Options by the Funds to the Issuer.
(4)  Pursuant to the Option Agreement, the Put Options may be exercised by the Funds at a per option price equal to the greater of (x) $14.50 and (y) 85% of the current market value of a share of Class A Common Stock on the date the Put Options are exercised, as determined in accordance with the terms of the Option Agreement.
(5)  Pursuant to the Option Agreement, both of the Put Options and the Call Options will become exercisable upon the closing date of a merger involving the Issuer, certain subsidiaries thereof, Solara Holdings, LLC and certain entities related thereto.
(6)  Pursuant to the Option Agreement, the Put Options and Call Options each relate to the shares of Class A Common Stock and Class B Common Stock held by the Funds, without distinguishing between such shares.

Remarks:
Dale Wolf serves as a director of the Issuer as the representative of AssuredIM. In connection therewith, AssuredIM may be deemed to be a director by deputization of the Issuer solely for purposes of Section 16(a) of the Exchange Act. As a result, AssuredIM is listed as a "Reporting Person" in Item 1 and the "Director" box is marked in Item 4 of this Form 4.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Assured Investment Management LLC
280 PARK AVENUE, 12TH FLOOR
NEW YORK, NY 10017
X



Signatures
Assured Investment Management LLC, By: /s/ Eric M. Albert, Chief Compliance Officer 10/20/2020
**Signature of Reporting Person Date